Vaccines, blood, antisera, toxins and cultures in   Equatorial Guinea

Exports In 2022, Equatorial Guinea exported $40.4M in Vaccines, blood, antisera, toxins and cultures, making it the 53rd largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 14th most exported product in Equatorial Guinea. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Equatorial Guinea are: Zambia ($40.4M) and Spain ($278).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Equatorial Guinea between N/A and 2022 were Zambia ($40.4M) and Spain ($278).

Imports In 2022, Equatorial Guinea imported $1.7M in Vaccines, blood, antisera, toxins and cultures, becoming the 190th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 146th most imported product in Equatorial Guinea. Equatorial Guinea imports Vaccines, blood, antisera, toxins and cultures primarily from: Zambia ($1.27M), United Kingdom ($98.5k), India ($88.7k), Canada ($59.2k), and Japan ($58.1k).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Equatorial Guinea between 2021 and 2022 were Zambia ($1.27M), India ($81.1k), and Canada ($59.2k).